CSI Market
Sign In | Register

Edwards Lifesciences (EW) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EW Annual Balance Sheets →
This page allows investors to track Edwards Lifesciences's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent2,906.50
Short-term Investments, Total1,385.20
Cash & Short-term Investments4,291.00
Accounts receivable770.40
Other Receivables, Net, Current185.30
Inventories1,131.20
Assets held for sale51.40
Disposal Group, Including Discontinued Operation, Assets, Current AS0.00
Other current assets25.80
Prepaid Expense, Current AS119.00
Total Current Assets6,818.90
Equipment/Property/Plant Net1,841.80
Goodwill net1,951.20
Intangible Assets1,382.60
Long-term investments244.10
Long-term recivables14.60
Deferred Tax Assets, Net, Noncurrent AS412.10
Prepaid pension89.20
Disposal Group, Including Discontinued Operation, Assets, Noncurrent AS0.00
Other Assets1,112.60
Operating Lease Right Of Use Asset99.30
Deferred Income Tax Assets Net1,098.10
Total Assets13,867.10
Liabilities
Accounts Payable, Current AC210.50
Accrued Liabilities, Current AC372.90
Other accrued expenses6.30
Other current liabilities0.00
Taxes Payable, Total1,006.90
Disposal Group, Including Discontinued Operation, Liabilities, Current LI7.50
Total Current Liabilities1,507.90
Long-term debt598.70
Total Long-term Debt598.70
Estimated Litigation Liability, Noncurrent LI9.80
Liability for Uncertain Tax Positions, Noncurrent LI572.20
Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent LI0.00
Other longterm liabilities357.40
Operating Lease Liability Current24.30
Operating Lease Liability Noncurrent80.10
Total Liabilities3,142.20
Stockholders' Equity
Treasury Stock Common Value-7,513.90
Common Stock Value661.70
Additional Paid In Capital Common Stock2,975.90
Retained Earnings / Accumulated Deficit14,863.10
Accumulated Other Comprehensive Income-214.60
Other Equity-214.60
Common Stockholder's Equity10,618.00
Non-controlling interests & other106.90
Total Stockholder's Equity10,724.90
Liabilities & Stockholder's Equity13,867.10
4 historic quarters locked

Sign in to unlock the full Edwards Lifesciences balance sheet history.

Sign In Create Free Account

About Edwards Lifesciences Corp Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 4, 2026
  • Source: ew-20260630.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001099800-26-000043

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.